ABEONA THERAPEUTICS INC. Uncategorized Contracts & Agreements
47 Contracts & Agreements
- Letter Agreement, dated February 28, 2022, between the Company and Joseph Vazzano (Filed With SEC on May 13, 2022)
- Letter Agreement, dated September 16, 2021, between the Company and Brendan OMalley (Filed With SEC on March 31, 2022)
- Letter Agreement, dated October 6, 2021, between the Company and Vishwas Seshadri (Filed With SEC on March 31, 2022)
- Amendment No. 1 to Open Market Sale Agreement, dated November 19, 2021, amending the Open Market Sale Agreement, by and between the Company and Jefferies LLC, dated August 17, 2018 (Filed With SEC on November 19, 2021)
- Letter Agreement, dated August 10, 2021, between the Company and Edward Carr (Filed With SEC on November 15, 2021)
- Letter Agreement, dated March 19, 2021, between the Company and Michael Amoroso (Filed With SEC on May 17, 2021)
- Amended and Restated Letter Agreement, dated January 27, 2021, between the Company and Michael Amoroso (Filed With SEC on May 17, 2021)
- Letter Agreement, dated October 26, 2020, between Abeona Therapeutics Inc. and Michael Amoroso (Filed With SEC on October 30, 2020)
- Amendment No. 3, dated April 14, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh (Filed With SEC on August 10, 2020)
- Offer Letter between Abeona Therapeutics Inc. and Edward Carr, dated June 18, 2020 (Filed With SEC on June 23, 2020)
- Amendment No. 2, dated March 31, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh (Filed With SEC on May 6, 2020)
- Letter Agreement, dated March 13, 2020, between the Company and Christine Berni Silverstein (Filed With SEC on May 6, 2020)
- Amendment No. 1, dated March 6, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh (Filed With SEC on May 6, 2020)
- Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh (Filed With SEC on May 6, 2020)
- Offer Letter, dated April 15, 2020, between Abeona Therapeutics Inc. and Brian J.G. Pereira, M.D (Filed With SEC on April 21, 2020)
- Letter Agreement regarding Certain Purchaser Rights, dated December 20, 2019, among the Company, Biomedical Value Fund, L.P., Biomedical Offshore Value Fund, Ltd., and GEF-SMA, L.P (Filed With SEC on December 23, 2019)
- Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and Edward Carr, dated November 9, 2018 (Filed With SEC on November 12, 2019)
- Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and Christine Berni Silverstein, dated January 8, 2019 (Filed With SEC on November 12, 2019)
- Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and Joo Siffert, M.D., dated February 11, 2019 (Filed With SEC on November 12, 2019)
- Offer Letter, dated February 11, 2019, by and between Abeona Therapeutics Inc. and Joo Siffert, M.D (Filed With SEC on February 13, 2019)
- Offer Letter, dated January 8, 2019, by and between Abeona Therapeutics Inc. and Christine Berni Silverstein (Filed With SEC on January 10, 2019)
- Letter Agreement between Abeona Therapeutics, Inc. and Joo Siffert, M.D., dated November 29, 2018 (Filed With SEC on November 30, 2018)
- Letter Agreement between Abeona Therapeutics, Inc. and Joo Siffert, M.D., dated September 28, 2018 (Filed With SEC on November 30, 2018)
- Offer Letter, effective October 19, 2018, by and between Abeona Therapeutics Inc. and Edward Carr (Filed With SEC on November 9, 2018)
- Letter of Agreement dated October 5, 2018 by and between the Company and Stephen B. Thompson (Filed With SEC on October 9, 2018)
- Open Market Sale Agreement, dated August 17, 2018, by and between the Company (Filed With SEC on August 20, 2018)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on August 14, 2015)
- ACCESS Pharmaceuticals, Inc. 1325 Avenue of the Americas, 27th Floor New York, New York10019 (Filed With SEC on September 24, 2014)
- ACCESS Pharmaceuticals, Inc. 1325 Avenue of the Americas, 27th Floor New York, New York10019 (Filed With SEC on September 24, 2014)
- ACCESS NEWS (Filed With SEC on October 25, 2012)
- ACCESS PHARMACEUTICALS ANNOUNCES PRIVATE PLACEMENT OF $5.2 MILLION (Filed With SEC on November 7, 2011)
- HUDSON SECURITIES, INC. LETTERHEAD December ___, 2010 (Filed With SEC on December 8, 2010)
- HUDSON SECURITIES, INC. LETTERHEAD November ___, 2010 (Filed With SEC on November 23, 2010)
- AMENDMENTTO RIGHTS AGREEMENT (Filed With SEC on March 23, 2010)
- EMPLOYMENTAGREEMENT (Filed With SEC on February 8, 2010)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on January 21, 2010)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on January 15, 2010)
- AMENDMENT TO EMPLOYMENTAGREEMENT (Filed With SEC on May 20, 2008)
- _____________________________________________________________________________ (Filed With SEC on March 11, 2008)
- DIRECTOR DESIGNATION AGREEMENT (Filed With SEC on March 11, 2008)
